Print

Stemline Therapeutics, Inc. (STML) to Present at the 25th Annual Roth Conference on March 20, 2013  
3/12/2013 12:51:36 PM

NEW YORK, March 12, 2013 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical-stage biopharmaceutical company developing oncology therapeutics that target both cancer stem cells (CSCs) and tumor bulk, announced today that Ivan Bergstein, M.D., Chief Executive Officer, will present at the 25th Annual Roth Conference on Wednesday, March 20th, 2013 at 8:00AM PT. The conference will take place at the Ritz-Carlton Laguna Niguel in Dana Point, California.
//-->